These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32450003)

  • 1. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease.
    Viveiros A; Panzer M; Baumgartner N; Schaefer B; Finkenstedt A; Henninger B; Theurl I; Nachbaur K; Weiss G; Haubner R; Decristoforo C; Tilg H; Zoller H
    Liver Int; 2020 Aug; 40(8):1941-1951. PubMed ID: 32450003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype.
    Uguen K; Le Tertre M; Tchernitchko D; Elbahnsi A; Maestri S; Gourlaouen I; Férec C; Ka C; Callebaut I; Le Gac G
    HGG Adv; 2024 Oct; 5(4):100335. PubMed ID: 39039793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
    Drakesmith H; Schimanski LM; Ormerod E; Merryweather-Clarke AT; Viprakasit V; Edwards JP; Sweetland E; Bastin JM; Cowley D; Chinthammitr Y; Robson KJ; Townsend AR
    Blood; 2005 Aug; 106(3):1092-7. PubMed ID: 15831700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients.
    Le Tertre M; Ka C; Guellec J; Gourlaouen I; Férec C; Callebaut I; Le Gac G
    Transfus Clin Biol; 2017 Nov; 24(4):462-467. PubMed ID: 28826751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload.
    Mohammad G; Matakidou A; Robbins PA; Lakhal-Littleton S
    Kidney Int; 2021 Sep; 100(3):559-569. PubMed ID: 33991530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
    Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M
    Bone; 2020 Aug; 137():115400. PubMed ID: 32380257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin in iron overload disorders.
    Papanikolaou G; Tzilianos M; Christakis JI; Bogdanos D; Tsimirika K; MacFarlane J; Goldberg YP; Sakellaropoulos N; Ganz T; Nemeth E
    Blood; 2005 May; 105(10):4103-5. PubMed ID: 15671438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited iron overload disorders.
    Piperno A; Pelucchi S; Mariani R
    Transl Gastroenterol Hepatol; 2020; 5():25. PubMed ID: 32258529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].
    Ohara K; Tsuge N; Watanabe S; Eda H; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Rinsho Ketsueki; 2023; 64(11):1410-1414. PubMed ID: 38072426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
    Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
    Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
    Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.